Explore
Validate
LearnNB100-79791
antibody from Novus Biologicals
Targeting: TRIP6
MGC10556, MGC10558, MGC29959, MGC3837, MGC4423, OIP1, ZRP-1
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NB100-79791 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#NB100-79791, RRID:AB_1111112
- Product name
- Rabbit Polyclonal TRIP6 Antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified.
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 100 ul
- Concentration
- 1.0 mg/ml
- Storage
- Store at 4C. Do not freeze.
Submitted references The adaptor protein TRIP6 antagonizes Fas-induced apoptosis but promotes its effect on cell migration.
Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect.
PTPL1/FAP-1 negatively regulates TRIP6 function in lysophosphatidic acid-induced cell migration.
TRIP6 transcriptional co-activator is a novel substrate of AMP-activated protein kinase.
TRIP6 is a RIP2-associated common signaling component of multiple NF-kappaB activation pathways.
Lai YJ, Lin VT, Zheng Y, Benveniste EN, Lin FT
Molecular and cellular biology 2010 Dec;30(23):5582-96
Molecular and cellular biology 2010 Dec;30(23):5582-96
Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect.
E S, Lai YJ, Tsukahara R, Chen CS, Fujiwara Y, Yue J, Yu JH, Guo H, Kihara A, Tigyi G, Lin FT
The Journal of biological chemistry 2009 May 22;284(21):14558-71
The Journal of biological chemistry 2009 May 22;284(21):14558-71
PTPL1/FAP-1 negatively regulates TRIP6 function in lysophosphatidic acid-induced cell migration.
Lai YJ, Lin WC, Lin FT
The Journal of biological chemistry 2007 Aug 17;282(33):24381-7
The Journal of biological chemistry 2007 Aug 17;282(33):24381-7
TRIP6 transcriptional co-activator is a novel substrate of AMP-activated protein kinase.
Solaz-Fuster MC, Gimeno-Alcañiz JV, Casado M, Sanz P
Cellular signalling 2006 Oct;18(10):1702-12
Cellular signalling 2006 Oct;18(10):1702-12
TRIP6 is a RIP2-associated common signaling component of multiple NF-kappaB activation pathways.
Li L, Bin LH, Li F, Liu Y, Chen D, Zhai Z, Shu HB
Journal of cell science 2005 Feb 1;118(Pt 3):555-63
Journal of cell science 2005 Feb 1;118(Pt 3):555-63
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: TRIP6 Antibody [NB100-79791] - Nuclear extract (NE) from HeLa cells. Antibody used at 0.3 ug/ml.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: TRIP6 Antibody [NB100-79791] - Detection of Human TRIP6 by Western Blot. Samples: Whole cell lysate (50 ug) from HeLa and 293T cells prepared using NETN lysis buffer. Antibody: Affinity purified rabbit anti-TRIP6 antibody NB100-79791 used for WB at 0.1 ug/ml. Detection: Chemiluminescence with an exposure time of 10 seconds.
